Mortality Risk Prediction in Patients With Antimelanoma Differentiation-Associated, Gene 5 Antibody-Positive, Dermatomyositis-Associated Interstitial Lung Disease: Algorithm Development and Validation.

导出 LinkOut

翻译打印收藏纠错

作者： Hui,Li ^[1] ; Ruyi,Zou ^[2] ; Hongxia,Xin ^[3] ; Ping,He ^[4] ; Bin,Xi ^[5] ; Yaqiong,Tian ^[2] ; Qi,Zhao ^[2] ; Xin,Yan ^[2] ; Xiaohua,Qiu ^[2] ; Yujuan,Gao ^[2] ; Yin,Liu ^[2] ; Min,Cao ^[2] ; Bi,Chen ^[5] ; Qian,Han ^[6] ; Juan,Chen ^[3] ; Guochun,Wang ^[7] ; Hourong,Cai ^[2]

作者单位： Department of Respiratory and Critical Care Medicine, Affiliated Drum Tower Hospital, Nanjing University Medical School, Nanjing, China.;Department of Pulmonary and Critical Care Medicine, Seventh Affiliated Hospital, Sun Yatsen University, Shenzhen, China. ^[1] Department of Respiratory and Critical Care Medicine, Affiliated Drum Tower Hospital, Nanjing University Medical School, Nanjing, China. ^[2] Department of Pulmonary and Critical Care Medicine, General Hospital of Ningxia Medical University, Yinchuan, China. ^[3] Department of Respiratory and Critical Care Medicine, Third People's Hospital of Chengdu, Chengdu, China. ^[4] Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China. ^[5] National Center for Respiratory Medicine, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. ^[6] China-Japan Friendship Hospital, Key Laboratory of Myositis (Beijing Key Laboratory for Immune Mediated Inflammatory Diseases), Department of Rheumatology, Beijing, China. ^[7]